NCT02254174View on ClinicalTrials.gov

Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2006

Conditions
Healthy
Interventions
DRUG

Tiotropium/Salmeterol

Fixed dose combination of tiotropium 7.5 μg and salmeterol 25 μg inhalation powder, PE capsule via HandiHaler®

DRUG

Serevent® Diskus®

DRUG

Spiriva®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY